Your browser doesn't support javascript.
loading
Author Correction: Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses.
McMillan, Christopher L D; Cheung, Stacey T M; Modhiran, Naphak; Barnes, James; Amarilla, Alberto A; Bielefeldt-Ohmann, Helle; Lee, Leo Yi Yang; Guilfoyle, Kate; van Amerongen, Geert; Stittelaar, Koert; Jakob, Virginie; Lebas, Celia; Reading, Patrick; Short, Kirsty R; Young, Paul R; Watterson, Daniel; Chappell, Keith J.
Afiliação
  • McMillan CLD; School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD, 4072, Australia. c.mcmillan1@uq.edu.au.
  • Cheung STM; School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD, 4072, Australia.
  • Modhiran N; School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD, 4072, Australia.
  • Barnes J; WHO Collaborating Centre for Reference and Research on Influenza, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, 3000, Australia.
  • Amarilla AA; School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD, 4072, Australia.
  • Bielefeldt-Ohmann H; School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD, 4072, Australia.
  • Lee LYY; Australian Infectious Diseases Research Centre, Global Virus Network Centre of Excellence, Brisbane, QLD, 4072 and 4029, Australia.
  • Guilfoyle K; School of Veterinary Science, The University of Queensland Gatton Campus, Gatton, QLD, 4343, Australia.
  • van Amerongen G; WHO Collaborating Centre for Reference and Research on Influenza, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, 3000, Australia.
  • Stittelaar K; Viroclinics Xplore, Landerd Campus, Nistelrooise Baan 3, 5374 RE, Schaijk, The Netherlands.
  • Jakob V; Viroclinics Xplore, Landerd Campus, Nistelrooise Baan 3, 5374 RE, Schaijk, The Netherlands.
  • Lebas C; Viroclinics Xplore, Landerd Campus, Nistelrooise Baan 3, 5374 RE, Schaijk, The Netherlands.
  • Reading P; Vaccine Formulation Institute, Chemin des Aulx 14, 1228 Plan-Les-Ouates, Geneva, Switzerland.
  • Short KR; Vaccine Formulation Institute, Chemin des Aulx 14, 1228 Plan-Les-Ouates, Geneva, Switzerland.
  • Young PR; WHO Collaborating Centre for Reference and Research on Influenza, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, 3000, Australia.
  • Watterson D; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, VIC, 3000, Australia.
  • Chappell KJ; School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD, 4072, Australia.
NPJ Vaccines ; 7(1): 3, 2022 Jan 05.
Article em En | MEDLINE | ID: mdl-34987159
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article